This is a deeply distressed micro-cap with a $346M market cap trading at 0.3x sales and 1.6x book, but the absence of any P/E or Forward P/E combined with an EPS of -2.9 and expected -1.41 next year confirms there is no earnings power to anchor valuation. The Altman Z-Score of 0.3 signals extreme financial distress risk, and with operating margins at -38.90% and ROIC at -40.70%, this business is destroying capital at an alarming rate. The market is not mispricing safety here—it is pricing in survival risk. This is a speculative turnaround at best, not a growth compounder, and the balance sheet and profitability metrics justify the discount.